A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 06cd75a95fd7a6feb15a2b59627573b32087bbe3
First added on: Feb 11, 2025